Cardiovascular involvement in thyroid disease;Kardiovaskulare Wirkungen von Schilddrusenhormonen

Zeitschrift fur Kardiologie

Volumn 85, Issue SUPPL. 6, 1996, Pages 219-231

  Mohr Kahaly, Susanne ^a   Kahaly, G ^a   Meyer, J ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

cardiovascular involvement; thyroid disease

Indexed keywords

LIOTHYRONINE; MYOSIN HEAVY CHAIN; THYROID HORMONE;

ATHEROSCLEROSIS; CONFERENCE PAPER; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTHYROIDISM; HYPOTHYROIDISM; MYXEDEMA; PATHOPHYSIOLOGY; VASCULAR RESISTANCE; ANIMAL; ARTERIOSCLEROSIS; ENERGY METABOLISM; HEART CONTRACTION; HEART DISEASE; HEMODYNAMICS; PHYSIOLOGY; REVIEW;

ANIMALS; ARTERIOSCLEROSIS; ENERGY METABOLISM; HEART DISEASES; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION; HYPERTHYROIDISM; HYPOTHYROIDISM; MYOCARDIAL CONTRACTION; MYXEDEMA; THYROID HORMONES;

EID: 0030339614     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (126)

1. Agner T, Almdal T, Thorsteinzson B, Agner E (1984) A reevaluation of atrial fibrillation in thyrotoxicosis. Dan med Bull 31: 157-9
2. Bahouth SW (1991) Thyroid hormones transcriptionally regulate the beta 1-adrenergic receptor gene in cultured ventricular myocytes. J Biol Chem 266 (24): 15863-9
3. Bakker O, van Beeren HC, Wiersinga WM (1994) Desethylamiodaronc is a noncompetitive inhibitor of the binding of thyroid hormone to the thyroid hormone beta 1-receptor protein. Endocrinology 134: 1665-70
4. Balkman C, Ojamaa K, Klein I (1992) Time course of the in vivo effects of thyroid hormone on cardiac gene expression. Endocrinology 130 (4): 2001-6
5. Bartalena L, Grasso L, Brogioni S, Aghini-Lombardi F, Braverman LE, Martino E (1994) Serum interleukin-6 in amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 78 (2): 423-7
6. Beaver WL, Wassermann K, Whipp BL (1986) A new method for detecting the anaerobic threshold by gas exchange. J Appl Physiol 60: 2020-7
7. Beeren HC, Baker O, Wiersinga WM (1995) Desethylamiodarone is a competitive inhibitor of the binding of thyroid hormone to the thyroid hormone alpha 1-receptor protein. Mol Cell Endocrinol 112: 15-9
8. 2 uptake in hyperthyroidism during constant work rate and incremental exercise. Eur J Appl Physiol 62: 261-7
9. Biagini A, Iervasi G, Clerico A, Berti S, Pilo A, Vitek F, Rita B, Bianchi R, Donato L (1995) Peripheral thyroid hormone metabolism in patients with complex ventricular arrhythmias. Am J Cardiol 75 (8): 630-3
10. Bischoff S, Kahaly G, Olshausen K, Mohr-Kahaly S, Erbel R, Beyer J, Meyer J (1988) Arrhythmieprofil und Herzfrequenz bei Hyperthyreose. Dtsch Med Wschr 113: 579-85
11. Bischoff S, Kahaly G, Olshausen K (1989) Das Langzeit-EKG bei Hyperthyreose. Der Kassenarzt 29: 47-51
12. Brennan MD, Erickson DZ, Carney JA, Bahn RS (1995) Nongoitrous (type 1) amiodarone-associated thyrotoxicosis: evidence of follicular disruption in vitro and in vivo. Thyroid 5: 177-83
13. Carey D, Hurst JW, Silverman ME (1992) Coronary spasm and cardiac arrest after coronary arteriography in unsuspected thyrotoxicosis. Am J Cardiol 70: 833-4
14. Channick BJ, Adlin EV, Marks AD, Denenberg BS, McDonough MT, Chakko CS, Spann JF (1981) Hyperthyroidism and mitral-valve prolapse. N Engl J Med 305 (9): 497-500
15. Chiovato L, Martino E, Tonacchera M, Santini F, Lapi P, Mammoli C, Braverman LE, Pinchera A (1994) Studies on the in vitro cytotoxic effect of amiodarone. Endocrinology 134(5): 2277-82
16. Chu SH, Huang TS, Hsu RB, Wang SS, Wang CJ (1991) Thyroid hormone changes after cardiovascular surgery and clinical implications. Ann Thorac Surg 52 (4): 791-6
17. Crowley WF Jr, Ridgway EC, Bough EW, Francis GS, Daniels GH, Kourides IA, Myers GS, Maloof F (1977) Noninvasive evaluation of cardiac function in hypothyroidism. Response to gradual thyroxine replacement. N Engl J Med 296 (1): 1-6
18. Davies MJ, Moore BP, Braimbridge MV (1978) The floppy mitral valve. Study of incidence, pathology, and complications in surgical, necropsy, and forensic material. Br Heart J 40 (5): 468-81
19. Dillmann WH (1990) Biochemical basis of thyroid hormone action in the heart. Am J Med 88: 626-30
20. Dillmann WH (1993) Cardiac function in thyroid disease: Clinical features and managment considerations. Ann Thorac Surg 56: S9-15
21. Drvota V, Janson A, Norman C, Sylven C, Häggblad J, Brönnegard M, Marcus C (1995) Evidence for the presence of functional thyrotropin receptor in cardiac muscle. Biochem Biophys Res Commun 211: 426-31
22. Drvota V, Brönnegard M. Haggblad J, Barkhem T. Sylven C (1995) Down-regulation of thyroid hormone receptor subtype mRNA levels by amiodarone during catecholamine stress in vitro. Biochem Biophys Res Commun 211: 991-6
23. Drvota V, Carlsson B, Haggblad J, Sylven C (1995) Amiodarone is a dose-dependent noncompetitive and competitive inhibitor of T3 binding to thyroid hormone receptor subtype beta 1, whereas disopyramide, lignocaine, propafenone, metoprolol, dl-sotalol, and verapamil have no inhibitory effect. J Cardiovasc Pharmacol 26 (2): 222-6
24. Dudley SC Jr, Baumgarten CM (1991) Bursting of cardiac sodium channels after acute exposure to 3,5.3′-triiodo-L-thyronine. Circ Res 73 (2): 301-13
25. Dulchavsky SA, Lucas CE, Ledger-wood AM, Grabow D, Brown TR, Bagchi N (1993) Triiodothyronine (T3) improves cardiovascular function during hemorrhagic shock. Circulatory Shock 39: 68-73
26. Dyke CM, Ding M, Abd-Elfattah, Loesser K, Dignan RJ, Wechsler AS, Salter DR (1993) Effects of triiodothyronine supplementation after myocardial ischemia. Ann Thorac Surg 56: 215-22
27. Ellyin FM, Kumar Y, Somberg JC (1992) Hypothyroidism complicated by angina pectoris: therapeutic approaches. J Clin Pharmacol 32: 843-7
28. Erbel R, Mortasawi A, Kramer G, Oelert H, Meyer J (1989) Das Mitral-klappenprolaps-Syndrom. Dtsch Med Wochenschr 114 (17): 678-87
29. Forfar JC, Muir AL, Toft AD (1982) Left ventricular function in hypothyroidism. Responses to exercise and beta adrenoceptor blockade. Br Heart J 48 (3): 278-84
30. Forfar JC, Sawers JSA, Muir AL, Toft AD (1982) Left Ventricular function in hyperthroidism. Evidence for reversible cardiomyopathy. N Engl J Med 307: 1165
31. Fuller H jr, Spitell JA jr, McLonahey WM (1965) Myxedema, a cause of reversible hypertension. Circulation 31: 91-2
32. Gay RG, Raya TE, Lancaster LD, Lee RW, Morkin E, Goldman S (1988) Effects of thyroid state on venous compliance and left ventricular performance in rats. Am J Physiol 254: H81-8
33. Goldman S, Olajos M, Morkin E (1984) Control of cardiac output in thyrotoxic calves. Evaluation of changes in the systemic circulation. J Clin Invest 73 (2): 358-65
34. Gotzsche LB (1994) Acute increase in cardiac performance after triiodothyronine: blunted response in amiodar-one-treated pigs. J Cardiovasc Pharmacol. 23 (1): 141-8
35. Gotzsche LB (1994) L-triiodothyronine acutely increases Ca2+ uptake in the isolated, perfused rat heart. Changes in L-type Ca2+ channels and beta-receptors during short- and long-term hyper- and hypothyroidism. Eur J Endocrinol 130 (2): 171-9
36. Gotzsche LB, Orskov H (1994) Cardiac triiodothyronine nuclear receptor binding capacities in amiodarone-treated, hypo- and hyperthyroid rats. Eur J Endocrinol 130 (3): 281-90
37. Hamilton MA, Stevenson LW, Luu M, Walden JA (1990) Altered thyroid hormone metabolism in advanced heart failure. J Am Coll Cardiol 16 (1): 91-5
38. Hammond HK, White FC, Buxton IL, Saltzstein P, Brunton LL, Longhurst JC (1987) Increased myocardial beta-receptors and adrenergic responses in hyperthyroid pigs. Am J Physiol 252: H283-9
39. Hansen C, Otto E, Kuhlemann K, Förster G, Kahaly G. Glycosaminoglycans in autoimmunity. Clin Exp Rheumatol (im Druck)
40. Hellermann J, Treese N, Mohr-Kahaly S, Beyer J, Kahaly G (1994) Kardiopulmonale Belastung bei Hyperthyreose, Z Kardiol 83: 38-43
41. Hellermann J, Kahaly G (1996) Kardiopulmonale Beteiligung bei Schild-drüsenerkrankungen. Pneumologie 50: 375-380
42. Holland FW, Brown PS, Clark RE (1992) Acute severe postischemic myocardial depression reversed by triiodothyronine. Ann Thorac Surg 54 (2): 301-5
43. Hylander B, Ekelund LG, Rosenqvist U (1983) The cardiovascular response at rest and during exercise in hypothyroid subjects to thyroxine substitution. Clin Cardiol 6: 116-24
44. Iwasaki T, Naka M, Hiramatsu K, Yamada T, Niwa A, Aizawa T, Murakami M, Ishihara M, Miyahara Y (1989) Echocardiographic studies on the relationship between atrial fibrillation and atrial enlargement in patients with hyperthyroidism of Graves' disease. Cardiology 76 (1): 10-7
45. Izumo S, Mahadavi V (1988) Thyroid hormone receptor alpha isoforms generated by alternative splicing differentially active myosine HC gene transcription. Nature 334: 539-42
46. Johnson AB, Webber J, Mansell P, Gallen I. Allison SP, MacDonald I (1995) Cardiovascular and metabolic responses to adrenaline infusion in patients with short-term hypothyroidism. Clin Endocrinol 43: 747-51
47. Kahaly G (1987) Graves' disease and mitral valve prolapse. JAMA 257: 22 (letter)
48. Kahaly G, Erbel R, Mohr-Kahaly S, Zenker G, Olshausen K, Krause U, Beyer J (1987) Morhus Basedow und Mitralklappenprolaps. Dtsch Med Wschr 112: 248-53
49. Kahaly G, Beyer J (1991) Kardiale Beteiligung bei Funktionstörungen der Schilddrüse. Dtsch Med Wschr 116: 1559-62
50. Kahaly G, Stover C, Otto E, Beyer J, Schuler M (1992) Glycosaminoglycans in thyroid-associated ophthalmopathy. Autoimmunity 13: 81-8
51. Kahaly G, Hansen C, Stover C, Kuhle-mann K, Beyer J, Otto E (1994) Glycosaminoglycans and endocrine orbitopathy. Exp Clin Endocrinol 101: 151-61
52. Kahaly G, Mohr-Kahaly S, Beyer J, Meyer J (1995) Left ventricular function analyzed by Doppler and echocardiographic methods in short-term hypothyroidism. Am J Cardiol 75: 645-8
53. Kahaly G, Mohr-Kahaly S, Beyer J, Meyer J (1995) Prevalence of myxomatous mitral valve prolapse in patients with lymphocytic thyroiditis. Am J Cardiol 76: 1309-10
54. Kahaly G, Hellermann J, Mohr-Kahaly S, Treese N (1996) Impaired cardiopulmonary exercise capacity in hyperthyroidism. Chest 109: 57-61
55. Karlsberg RP, Friscia DA, Aronow WS, Sekhon SS (1981) Deleterious influence of hypothyroidism on evolving myocardial infarction in conscious dogs. J Clin Invest 67: 1024-34
56. Keating FR, Parkin TW, Selby JB, Dickson LS (1960) Treatment of heart disease associated with myxedema. Prog Cardiovasc Dis 3: 364-81
57. Kendrick AH, O'Reilly JF, Laszlo G (1988) Lung function and exercise performance in hyperthyroidism before and after treatment. Q J Med 68 (256): 615-27
58. Khalleli AA, Griffith DG, Edwards RHT (1987) The clinical presentation of hypothyroid myopathy and its relationship to abnormalities in structure and function of skeletal muscle. Clin Endocrinol 19: 365-76
59. Klein I, Levey GS (1984) Unusual manifestations of hypothyroidism. Arch Intern Med 144: 123-8
60. Klein I, Hong C (1986) Effects of thyroid hormone on cardiac size and myosin content of the heterotopically transplanted rat heart. J Clin Invest 77 (5): 1694-8
61. Klein I (1990) Thyroid hormone and the cardiovascular system. Am J Med 88 (6): 631-7
62. Klein I, Ojamaa K (1994) Editorial: Thyroid hormone and the cardiovascular system: from theory to practice. J Clin Endocrinol Metab 78: 1026-7
63. Klemperer JD, Klein I, Gomez M, Helm RE, Ojamaa K, Thomas SJ, Isom OW, Krieger K (1995) Thyroid hormone treatment after coronary-artery bypass surgery. N Engl J Med 333 (23): 1522-7
64. Lavin IN (1989) Mechanisms of action of thyroid hormone. In: DeGroot LJ (Hrsg): Endocrinology. Vol 1. Saunders Company. Philadelphia. London Toronto: 562-573
65. Levey GS, Klein I (1990) Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism Am J Med 88 (6): 642-6
66. Lowenstein E (1993) Implications of triiodothyronine administration before cardiac and noncardiac operations. Ann Thorac Surg 56: S43-7
67. Lüderitz B (1982) Zur Kardiologie der Hyper- und Hypothyreose. Akt Endokr Stoffw 3: 89-94
68. Lüderitz B (1984) Gibt es eine thyreotoxische Kardiomyopathie? Dtsch Med Wschr 109: 203-4
69. Lüderitz B, Biersack HJ (1993) Kardiale Beteiligung bei Schilddrüsen-erkrankungen. Akt Endokr 14: 60-6
70. Maciel BC, Gallo L Jr, Marin Neto JA, Maciel LM, Martins LE (1988) Autonomic control of heart rate during dynamic exercise in human hyperthyroidism. Clin Sci 75 (2): 209-15
71. MacKerrow SD, Osborn LA, Levy H, Eaton RP, Economou P (1992) Myxedema associated cardiogenic shock treated with intravenous triiodothyronine. Ann Intern Med 15, 117 (12): 1014-5
72. Magyar CE, Wang J, Azuma KK, McDonough AA (1995) Reciprocal regulation of cardiac Na-K-ATPase and Na/Ca exchanger: hypertension, thyroid hormone, development. Am J Physiol 269: C675-82
73. Malcolm AD (1985) Mitral valve prolapse associated with other disorders. Casual coincidence, common link, or fundamental genetic disturbance? Br Heart J 53 (4): 353-62
74. Marks AR, Choong CY, Sanfilippo AJ, Ferre M. Weyman AE (1989) Identification of high-risk and low-risk sub-groups of patients with mitral-valve prolapse. N Engl J Med 320 (16): 1031-6
75. Martin WH, Spina RJ, Korte E, Yarasheski KE, Angelopoulos TJ, Nemeth PM, Saffitz JE (1991) Mechanisms of impaired exercise capacity in short duration experimental hyperthyroidism. J Clin Invest 88 (6): 2047-53
76. Martin WH, Spina RJ, Korte E (1992) Effect of hyperthyroidism of short duration on cardiac sensitivity to beta-adrenergic stimulation. J Am Coll Cardiol 19 (6): 1185-91
77. Martino E, Aghini-Lombardi F, Bartalena L, Grasso L, Loviselli A, Velluzzi F, Pinchera A, Braverman LE (1994) Enhanced susceptibility to amiodar-one-induced hypothyroidism in patients with thyroid autoimmune disease. Arch Intern Med 154: 2722-6
78. Massey DG, Becklake MR, McKenzie JM, Bates DV (1967) Circulatory and ventilatory response to exercise in thyrotoxicosis. N Engl J Med 276: 1104-12
79. McElvaney GN, Wilcox PG, Fairbarn MS et al. (1990) Respiratory muscle weakness and dyspnea in thyrotoxic patients. Am Rev Respir Dis 141: 1221-27
80. Mintz G, Pizzarello R, Klein I (1991) Enhanced left ventricular diastolic funtion in hyperthyroidism: Noninvasive assessment and response to treatment. J Clin Endocrinol Metab 73: 146-50
81. Mohr-Kahaly S, Erbel R, Zenker G, Drexler M, Wittlich N, Schaudig M, Bohlander M, Esser M, Meyer J (1989) Semiquantitative grading of mitral regurgitation by color-coded Doppler echocardiography. Int J Cardiol 23: 223-30
82. Mohr-Kahaly S, Erbel R, Zenker G, Bohlander M, Esser M, Meyer J (1989) Flow patterns of mitral regurgitation due to different etiologies: analysis by color-coded Doppler echocardiography. Int J Cardiol 23: 231-7
83. Moruzzi P, Doria E, Agostini PG, Capacchione V, Sganzerla P (1994) Usefulness of L-Thyroxine to improve cardiac and exercise performance in idiopathic dilated cardiomyopathy. Am J Cardiol 73: 374-8
84. Myasinikow AL, Zaitzev VF (1963) The influence of thyroid hormones on cholesterol metabolism in experimental atherosclerosis in rabbits. J Atheroseler Res 3: 295-306
85. Northcote RJ, McFarlane P, Kesson CM, Ballantyne D (1986) Continous 24-hour electocardiography in thyrotoxicosis before and afte treatment. Am Heart J 112: 339-44
86. Novitzky D, Cooper DK, Chaffin JS, Greer AE, DeBault LE, Zuhde N (1990) Improved cardiac allograft function following triiodothyronine therapy to both donor and recipient. Transplantation 49: 311-6
87. Ojamaa K, Samarel AM, Kupfer JM, Hong C, Klein I (1992) Thyroid hormone effects on cardiac gene expression independent of cardiac growth and protein synthesis. Am J Physiol 263: E534-40
88. Olshausen K, Bischoff S, Kahaly G, Mohr-Kahaly S, Erhel R, Beyer J, Meyer J (1989) Cardiac arrhythmias and heart rate in hyperthyroidism. Am J Cardiol 63: 930-3
89. Olson BR, Klein I, Benner R, Burdett R, Trzepacz P, Levey GS (1991) Hyperthyroid myopathy and the response to treatment. Thyroid 1: 137-41
90. Orlowski JP, Specs EK (1993) Improved cardiac transplant survival with thyroxine treatment of hemodynamically unstable donors: 95.2 % graft survival at 6 and 30 months. Transplantation Proceedings 25: 1535
91. Otto E, Förster G, Kuhlemann K, Hansen C, Kahaly G (1996) TSH receptor in endocrine autoimmunity. Clin Exp Rheumatol (im Druck)
92. Parker JLW, Lawson DH (1973) Death from thyrotoxicosis. Lancet II: 894-6
93. Parry CH (1828) Diseases of the heart. Collected works, vol 1: 478
94. Parving HH, Hansen JM, Nielsen SL, Rossing N, Munck O, Lassen NA (1979) Mechanisms of edema formation in myxedema-increased protein extravasation and relatively slow lymphatic drainage. N Engl J Med 301: 460-5
95. Pies M, Hellermann J, Treese N, Mohr-Kahaly S, Beyer J, Meyer J, Kahaly G (1995) Kardiovaskuläre Parameter bei passagerer Kurzzeithypothyreose. Z Kardiol 84: 668-74
96. Polikar R, Feld GK, Dittrich HC, Smith J, Nicod P (1989) Effect of thyroid replacement therapy on the frequency of benign atrial and ventricular arrhythmias. J Am Coll Cardiol 14: 999-1002
97. Polikar R, Kennedy B, Maisel A, Ziegler M, Smith J, Dittrich H, Nicod P (1990) Decreased adrenergic sensitivity in patients with hypothyroidism. J Am Coll Cardiol 15: 94-8
98. Polikar R, Burger AG, Scherrer U, Nicod P (1993) The thyroid and the heart. Circulation 87: 1435-41
99. Proskey AJ, Saksena F, Towne WD (1971) Myocardial infarction associated with thyrotoxicosis. Chest 72: 109-13
100. Rohrer D, Dillmann WH (1988) Thyroid hormone markedly increases mRNA coding for sarcoplasmic reticulum Ca++- ATPase in the rat heart. J Biol Chem 263: 6941-4
101. Sap J, Munoz A, Damm K, Goldberg Y, Ghysdael J, Leutz A, Beug H, Vennstrom B (1986) The c-erb-A-protein is a high affinity receptor for thyroid hormone. Nature 324: 635-40
102. Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, Wilson PWF, Benjamin EJ, D'Agostino RB (1994) Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 331: 1249-51
103. Segal J (1989) Acute effect of thyroid hormone on the heart: an extranuclear increase in sugar uptake. J Mol Cell Cardiol 21: 323-34
104. Segal J (1990) Calcium is the first messenger for the action of thyroid hormone at the level of the plasma membrane: first evidence for an acute effect of thyroid hormone on calcium uptake in the heart. Endocrinology. 126 (5): 2693-702
105. Sherman SI, Ladenson PW (1991) Percutaneous transluminal coronary angioplasty in hypothyroidism. Am J Med. 90 (3): 367-70
106. Shirani J, Barron MM, Pierre Louis ML, Roberts WC (1993) Congestive heart failure, dilated cardiac ventricles, and sudden death in hyperthyroidism. Am J Cardiol 72 (3): 365-8
107. Siehl D, Chua BH, Lautensack Belser N Morgan HE (1985) Faster protein and ribosome synthesis in thyroxin-induced hypertrophy of rat heart. Am J Physiol 248: C309-19
108. Sietsema KE, Daly JA, Wasserman K (1989) Early dynamics of O uptake and heart rate as affected by exercise work rate. J Appl Physiol 67: 2535-41
109. Singh AM, Umeda PK, Kavinsky CJ, Rajamanickam C, Hsu JJ (1982) Molecular cloning of mRNA sequences for cardiac alpha- and beta-form myosin heavy chains: expression in ventricles of normal, hypothyroid and thyotoxic rabbits. Proc Natl Acad Sci USA 79: 5847-51
110. Skowsky RW, Kikuchi TA (1978) The role of vasopressin in the impaired water excretion of myxedema. Am J Med 64: 613-21
111. Smith TJ, Murata J, Horwitz AL (1982) Regulation of glycosaminoglycan synthesis by thyroid hormone in vitro. J Clin Invest 70: 1066-72
112. Steinberg AD (1968) Myxedema and coronary artery disease. A comparative autopsy study. Ann Intern Med 68: 338-46
113. Stiles GL, Lefkowitz RJ (1981) Thyroid hormone regulation of agonist-beta adrenergic receptor interactions in the rat heart. Life Sci 28: 2529-36
114. Streeten DH, Anderson GH Jr, Howland T, Chiang R, Smulyan H (1988) Effects of thyroid function on blood pressure. Recognition of hypothyroid hypertension. Hypertension 11 (1): 78-83
115. Tisdale JE, Follin SL, Ordelova A, Webb CR (1995) Risk factor for the development of specific noncardiovascular adverse effects associated with amiodarone. J Clin Pharmacol 35: 351-6
116. Tseng KH, Walfish PG, Persaud JA, Gilbert BW (1989) Concurrent aortic and mitral valve echocardiography permits measurement of systolic time intervals as an index of peripheral tissue thyroid functional status. J Clin Endocrinol Metab 69: 633-8
117. Umpierrez GE, Challapalli S, Patterson C (1995) Congestive heart failure due to reversible cariomyopathy in patients with hyperthyroidism. Am J Med Sci 310 (3): 99-102
118. Venkatesh N, Lynch JJ, Uprichard ACG, Kitzen JN, Singh BN, Lucchesi BR (1991) Hypothyroidism renders protection against lethal ventricular arrythmia in a conscious canine model of sudden death. J Cardiovasc Pharmacol 18: 703-10
119. Wassermann K, Beaver W, Whipp BJ (1990) Gas exchange theory and the lactic acidosis (anaerobic) threshold. Circulations 81: 14-30
120. Weinberger C, Thompson CC, Ong ES, Lebo R, Gruol DJ, Evans RM, (1986) The c-erb-A-gene encodes a thyroid hormone receptor. Nature 324: 641-6
121. Wilkin TJ (1983) Hyperthyroidism and the heart. Brit med J 286: 1459-64
122. Woeher KA (1992) Thyrotoxicosis and the heart. N Engl J Med 327: 94-8
123. Yao J, Eghhali M (1992) Decreased collagen gene expression and absence of fibrosis in thyroid hormone-induced myocardial hypertrophy. Circ Res 71: 831-9
124. Zarain-Hezherg A, Marques J, Sukovich D (1994) Thyroid hormone receptor modulates the expression of the rabbit cardiac sarco(endo)plasmic reticulum Ca +-ATPase gene. J Biol Chem 269: 1460-7
125. Zenker G, Erbel R, Krämer G, Mohr-Kahaly S, Drexler M, Harnoncourt K, Meyer J (1988) Transoesophageal two-dimensional echocardiography in young patients with cerebral ischemic events. Stroke 19: 345-8
126. Zondek H (1918) Das Myxödemherz. MMW 65: 1180-82